AUM Biosciences Overview
- Year Founded
-
2018
- Status
-
Private
- Employees
-
19
- Latest Deal Type
-
Later Stage VC
- Investors
-
8
AUM Biosciences General Information
Description
Developer of an oncology-focused biotechnology platform designed to help in harnessing the power of digital and precision medicine. The company utilizes a proprietary partnered AI-augmented platform to systematically discover and develop targeted cancer therapies focused on genetic targets, enabling patients to access the right medicines at the right time.
Contact Information
Website
www.aumbiosciences.comCorporate Office
- 10 Anson Road
- Level 24 - Unit 16A/B, International Plaza
- Singapore, 079903
- Singapore
Corporate Office
- 10 Anson Road
- Level 24 - Unit 16A/B, International Plaza
- Singapore, 079903
- Singapore
AUM Biosciences Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Later Stage VC | 01-Feb-2026 | Completed | Clinical Trials - Phase 2 | |||
| 3. Reverse Merger | 19-Oct-2022 | Cancelled | Clinical Trials - Phase 2 | |||
| 2. Early Stage VC (Series A) | 12-Oct-2021 | $27M | $29.7M | Completed | Clinical Trials - Phase 2 | |
| 1. Seed Round | 25-Jun-2018 | $2.71M | $2.71M | Completed | Startup |
AUM Biosciences Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A | ||||||||
| Seed |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
AUM Biosciences Comparisons
Industry
Financing
Details
AUM Biosciences Competitors (19)
One of AUM Biosciences’s 19 competitors is CytomX Therapeutics, a Formerly VC-backed company based in South San Francisco, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| CytomX Therapeutics | Formerly VC-backed | South San Francisco, CA | ||||
| Cristal Therapeutics | Venture Capital-Backed | Maastricht, Netherlands | ||||
| Selecta Biosciences | Formerly VC-backed | Watertown, MA | ||||
| Meditope Biosciences | Formerly VC-backed | Pasadena, CA | ||||
| Cytovance Biologics | Formerly PE-Backed | Oklahoma City, OK |
AUM Biosciences Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
AUM Biosciences Patents
AUM Biosciences Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026187299-A1 | Method of treatment for obesity and cardiometabolic disorders | Pending | 06-Mar-2025 |
AUM Biosciences Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
AUM Biosciences Investors (8)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Agency for Science, Technology and Research | Government | Minority | ||
| Accelerate Technologies | Corporation | Minority | ||
| Everlife Asia | PE-Backed Company | Minority | ||
| Angel (individual) | Minority | |||
| SPRIM Global Investments | Holding Company | Minority |
AUM Biosciences FAQs
-
When was AUM Biosciences founded?
AUM Biosciences was founded in 2018.
-
Where is AUM Biosciences headquartered?
AUM Biosciences is headquartered in Singapore, Singapore.
-
What is the size of AUM Biosciences?
AUM Biosciences has 19 total employees.
-
What industry is AUM Biosciences in?
AUM Biosciences’s primary industry is Drug Discovery.
-
Is AUM Biosciences a private or public company?
AUM Biosciences is a Private company.
-
What is AUM Biosciences’s current revenue?
The current revenue for AUM Biosciences is .
-
How much funding has AUM Biosciences raised over time?
AUM Biosciences has raised $29.7M.
-
Who are AUM Biosciences’s investors?
Agency for Science, Technology and Research, Accelerate Technologies, Everlife Asia, , and SPRIM Global Investments are 5 of 8 investors who have invested in AUM Biosciences.
-
Who are AUM Biosciences’s competitors?
CytomX Therapeutics, Cristal Therapeutics, Selecta Biosciences, Meditope Biosciences, and Cytovance Biologics are some of the 19 competitors of AUM Biosciences.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
